B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Table 2
Baseline self-reported symptom scores, baseline Function level, and baseline norm-based SF-36 scores, for 28 patients receiving rituximab induction and maintenance treatment.